⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IPHA News
Innate Pharma S.A. ADS
Innate Pharma to Participate in the D. Boral Capital Global Conference
businesswire.com
IPHA
Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight
globenewswire.com
AZN
CRSP
NKTR
INCY
IPHA
ABBV
BIIB
ALKS
IMVT
CLRB
IMPP
REGN
THO
AUTL
KYMR
CBIO
GILD
Improved Pharma Scientists to Present at Spring Pharmaceutical Synchrotron-XRPD Workshop May 6-8 in Basel, Switzerland
prnewswire.com
IPHA
Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026
businesswire.com
IPHA
Innate Pharma présentera des résultats intermédiaires de l’essai de Phase 2 MATISSE évaluant IPH5201 lors d’une session plénière dédiée aux essais cliniques au congrès de l’AACR 2026
businesswire.com
IPHA
Antibody Drug Conjugates (ADC) Market Research and Competitive Landscape Report 2026 - Extensive Analysis of Over 180 Companies and More Than 290 Drugs
globenewswire.com
GILD
ABBV
IPHA
L’assemblée générale d’Innate Pharma aura lieu le 21 mai 2026
businesswire.com
IPHA
Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026
businesswire.com
IPHA
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026
businesswire.com
IPHA
L’assemblée générale d’Innate Pharma aura lieu le 21 mai 2026
businesswire.com
IPHA